Learning from Hackers: Open-Source Clinical Trials

The open-source software movement can serve as a model for a similar initiative in the clinical trial community. Open sharing of clinical trial data has been proposed as a way to address the gap between the production of clinical evidence and the decision-making of physicians. A similar gap was addressed in the software industry by their open-source software movement. Here, we examine how the social and technical principles of the movement can guide the growth of an open-source clinical trial community.

[1]  P. Glasziou,et al.  Avoidable waste in the production and reporting of research evidence , 2009, The Lancet.

[2]  Sharon F. Terry,et al.  Power to the People: Participant Ownership of Clinical Trial Data , 2011, Science Translational Medicine.

[3]  Junhua Li,et al.  Open-source genomic analysis of Shiga-toxin-producing E. coli O104:H4. , 2011, The New England journal of medicine.

[4]  Steven Levy,et al.  Hackers: Heroes of the Computer Revolution , 1984 .

[5]  Nicholas C. Ide,et al.  The ClinicalTrials.gov results database--update and key issues. , 2011, The New England journal of medicine.

[6]  A. Edwards,et al.  Leveraging Crowdsourcing to Facilitate the Discovery of New Medicines , 2011, Science Translational Medicine.

[7]  Josh Lerner,et al.  The Simple Economics of Open Source , 2000 .

[8]  R. Collins,et al.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.

[9]  K. Mandl,et al.  The Role and Impact of Research Agendas on the Comparative‐Effectiveness Research Among Antihyperlipidemics , 2012, Clinical pharmacology and therapeutics.

[10]  E. Coiera,et al.  Research Paper: Building a National Health IT System from the Middle Out , 2009, J. Am. Medical Informatics Assoc..

[11]  I. Leviton,et al.  Registering clinical trials. , 2003, JAMA.

[12]  M. Cabana,et al.  Why don't physicians follow clinical practice guidelines? A framework for improvement. , 1999, JAMA.

[13]  Frank Davidoff,et al.  Delivering clinical evidence where it's needed: building an information system worthy of the profession. , 2011, JAMA.

[14]  H. Bastian,et al.  Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up? , 2010, PLoS medicine.

[15]  Andrea Bonaccorsi,et al.  Comparing motivations of individual programmers and firms to take part in the open source movement: From community to business , 2006 .

[16]  Bernard H. Munos,et al.  How to Revive Breakthrough Innovation in the Pharmaceutical Industry , 2011, Science Translational Medicine.

[17]  Fred Wood,et al.  Evolution and Implementation of the CDISC Study Data Tabulation Model (SDTM) , 2008 .

[18]  D. Estrin,et al.  Open mHealth Architecture: An Engine for Health Care Innovation , 2010, Science.

[19]  Bruce Alberts,et al.  Making Data Maximally Available , 2011, Science.

[20]  A. Bonaccorsi,et al.  Comparing Motivations of Individual Programmers and Firms to Take Part in the Open Source Movement. From Community to Business , 2006 .

[21]  R. Riley,et al.  Meta-analysis of individual participant data: rationale, conduct, and reporting , 2010, BMJ : British Medical Journal.

[22]  T. Kotchen.  Why the slow diffusion of treatment guidelines into clinical practice? , 2007, Archives of internal medicine.

[23]  B. Munos,et al.  A Call for Sharing: Adapting Pharmaceutical Research to New Realities , 2009, Science Translational Medicine.

[24]  Joshua C. Denny,et al.  The disclosure of diagnosis codes can breach research participants' privacy , 2010, J. Am. Medical Informatics Assoc..

[25]  Charles C. Persinger,et al.  How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.

[26]  I. Sim,et al.  Beyond Trial Registration: A Global Trial Bank for Clinical Trial Reporting , 2005, PLoS medicine.

[27]  P. Gøtzsche,et al.  Opening up data at the European Medicines Agency , 2011, BMJ : British Medical Journal.

[28]  Nicolas Rasmussen,et al.  Association of trial registration with the results and conclusions of published trials of new oncology drugs , 2009, Trials.

[29]  Thomas W. Valente,et al.  Opinion Leadership and Social Contagion in New Product Diffusion , 2011, Mark. Sci..

[30]  Giancarlo Succi,et al.  An empirical study of open-source and closed-source software products , 2004, IEEE Transactions on Software Engineering.

[31]  Kenneth D. Mandl,et al.  Outcome Reporting Among Drug Trials Registered in ClinicalTrials.gov , 2010, Annals of Internal Medicine.

[32]  M. Boguski,et al.  Repurposing with a Difference , 2009, Science.

[33]  Sean Gallagher,et al.  Engineering Efficient Technology Transfer , 2011, Science Translational Medicine.

[34]  Mary K. Kowal,et al.  Availability of comparative efficacy data at the time of drug approval in the United States. , 2011, JAMA.

[35]  D. Fourney.  Commentary , 2011, Evidence-based spine-care journal.